[Treatment of cerebro-cardiac insufficiency with Encephabol-Digoxin].
D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D004077:Digoxin / Q000009:adverse effects / Q000627:therapeutic use*; D004220:Disulfides / Q000627:therapeutic use; D004338:Drug Combinations; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D006331:Heart Diseases / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D011736:Pyridoxine / Q000627:therapeutic use*
D004220:Disulfides; D004338:Drug Combinations; D004077:Digoxin; D011736:Pyridoxine
Zur Behandlung der zerebro-kardialen Insuffizienz mit Encephabol -Digoxin.